4.8 Article

The shieldin complex mediates 53BP1-dependent DNA repair

Journal

NATURE
Volume 560, Issue 7716, Pages 117-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41586-018-0340-7

Keywords

-

Funding

  1. Dutch Cancer Society (KWF)
  2. CIHR
  3. European Research Council [CoG-50364, CoG-681572, SyG-319661]
  4. MD Anderson Cancer Center Support [P30 CA016672]
  5. Cancer Prevention Research Institute of Texas [CPRIT/RR160032]
  6. CIHR [PJT153307, FDN143301, FDN143343]
  7. Cancer Research UK [CRUK/A14276]
  8. Breast Cancer Now [CTR-Q4-Y2]
  9. Dutch Cancer Society [KWF 2014-6532]
  10. Netherlands Organization for Scientific Research [VICI 91814643]
  11. Swiss National Science Foundation [310030_ 156869]
  12. Canadian Cancer Society (CCS) [705644]
  13. OICR grant OICR-OC-TRI
  14. Swiss National Science Foundation (SNF) [310030_156869] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

53BP1 is a chromatin-binding protein that regulates the repair of DNA double-strand breaks by suppressing the nucleolytic resection of DNA termini(1,2). This function of 53BP1 requires interactions with PTIP3 and RIF1(4-9), the latter of which recruits REV7 (also known as MAD2L2) to break sites(10,11). How 53BP1-pathway proteins shield DNA ends is currently unknown, but there are two models that provide the best potential explanation of their action. In one model the 53BP1 complex strengthens the nucleosomal barrier to end-resection nucleases(12,13), and in the other 53BP1 recruits effector proteins with end-protection activity. Here we identify a 53BP1 effector complex, shieldin, that includes C20orf196 (also known as SHLD1), FAM35A (SHLD2), CTC-534A2.2 (SHLD3) and REV7. Shieldin localizes to double-strand-break sites in a 53BP1- and RIF1-dependent manner, and its SHLD2 subunit binds to single-stranded DNA via OB-fold domains that are analogous to those of RPA1 and POT1. Loss of shieldin impairs non-homologous endjoining, leads to defective immunoglobulin class switching and causes hyper-resection. Mutations in genes that encode shieldin subunits also cause resistance to poly(ADP-ribose) polymerase inhibition in BRCA 1-deficient cells and tumours, owing to restoration of homologous recombination. Finally, we show that binding of single-stranded DNA by SHLD2 is critical for shieldin function, consistent with a model in which shieldin protects DNA ends to mediate 53BP1-dependent DNA repair.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available